Speakers

  • Robert Nussbaum MD, FACP, FACMG
    Chief Medical Officer, Invitae
    Biography
      Dr. Nussbaum is currently the Chief Medical Officer of Invitae, a genetic information and diagnostic company. From 2006-2015, he was the Holly Smith Professor of Medicine at UCSF, Chief of the Division of Genomic Medicine, director of the Genomic Medicine Initiative at UCSF, and Medical Director of both the Cancer Risk Program at the Helen Diller Family Cancer Center and the UCSF Program in Cardiovascular Genetics, where he continues to see patients as a volunteer clinical faculty member. He came to UCSF in 2006 from the Division of Intramural Research of the National Human Genome Research Institute, NIH, where he served for 12 years as Chief of the Genetic Diseases Research and Inherited Disease Research Branches. Before his time at NIH, he was a faculty member in the Department of Genetics at the University of Pennsylvania and an Attending Physician at Children's Hospital of Philadelphia. He received his training in medicine in the Harvard-MIT Joint Program in Health Technology, his internal medicine training at Barnes Hospital/Washington University, and his genetics training at Baylor College of Medicine. He is board certified in internal medicine, clinical genetics and clinical molecular genetics. Dr. Nussbaum directed the original research that led to the discovery of mutations in -synuclein in hereditary Parkinson disease in the mid 1990's and studied its role in Parkinson disease for nearly 20 years. For his work on Parkinson disease, he was awarded the Klaus Joachim Zülch-Prize for Neurological Research and the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research. He also carried out positional cloning and characterization of the gene mutated in Lowe syndrome that led to accurate biochemical and molecular genetic testing, for which he has been recognized three times with awards from the Lowe Syndrome Association. He is the co-author of over 200 peer-reviewed publications on a broad range of topics in basic and applied human genetics and is co-author with Drs. Roderick M. McInnes and Huntington F. Willard of the popular textbook of human genetics, Thompson and Thompson's Genetics in Medicine. He has received numerous teaching awards from the University of Pennsylvania, the National Human Genome Research Institute and the University of California, San Francisco, and was awarded the Excellence in Education Award of the American Society of Human Genetics with his co-authors Drs. Willard and McInnes. Dr. Nussbaum is a Director and Treasurer of the American Board of Medical Genetics and Genomics and has served on the Board of Directors of the American College of Medical Genetics and Genomics and on the Board of the American Society of Human Genetics, where he also served as President. He was elected to the Institute of Medicine in 2004 and the American Academy of Arts and Sciences in 2015.
    • Christopher Mason, PhD
      Associate Professor Weill Cornell Medicine WorldQuant (WQ) Scholar & Director, WQ Initiative for Quantitative Prediction
      Biography
        Dr. Christopher Mason completed his dual B.S. in Genetics and Biochemistry (2001) from University of Wisconsin-Madison, his Ph.D. in Genetics (2006) from Yale University, and then completed post-doctoral training in clinical genetics (2009) at Yale Medical School, and a joint post-doctoral Fellow of Genomics, Ethics, and Law at Yale Law School (2009). He is currently an Associate Professor at Weill Cornell Medicine, with appointments at the Tri-Institutional Program on Computational Biology and Medicine, the Meyer Cancer Center, and the Feil Family Brain and Mind Research Institute. The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and human physiology. We create and explore novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods, to ensure clinical-quality genome measurements/editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which establish the molecular foundations and genetic defenses for enabling long-term human space travel. He has won the NIH's Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He has >130 peer-reviewed papers that have been featured on the covers of Nature, Science, Cell Host and Microbe, Nature Biotechnology, Nature Microbiology, and many others.He was named as one of the "Brilliant Ten" Scientists by Popular Science, featured as a TEDMED speaker, and called "The Genius of Genetics" by 92Y.
      • Catherine Behrens, MD, PhD, FACOG
        Consultant Senior Director, Clinical Research
        Biography
          Catherine Behrens did her PhD research at University of California San Francisco and attended medical school at Stanford University. She completed a Residency in Obstetrics and Gynecology, also at Stanford. Dr. Behrens was in clinical practice for over 20 years and maintains board certification from the American College of Obstetricians and Gynecologists. Dr. Behrens returned to research in the women's health field, initially at Genomic Health and then serving as Senior Director for Clinical Research at Roche Molecular Diagnostics from 2009 until 2015. During her tenure at Roche, Dr. Behrens was the clinical lead for the ATHENA study and a number of additional registrational trials. She currently serves as a consultant in women's health care.
        • Condie Carmack, PhD
          Vice President of Precision Oncology, Vela Dx
          Biography
            Condie Carmack, Ph.D. received his Ph.D. from the University of Utah in Experimental Pathology and did postdocs in Philadelphia, PA and San Diego, CA. in mouse genetics and molecular biology. He is the author or or co-author of 23 peer-reviewed journal. He wrote the first paper on quantitative PCR and the second paper on multiplex PCR. He served on the Science Advisory Board of Life Technologies Inc. as an expert in clinical PCR. He was co-author on the first paper creating human monoclonal antibodies from immunodeficient mice. Mice serve as the foundation for creation of the current immune checkpoint blockade antibodies such as ipilimumab and nivolumab. He also served as General Manager of the Cancer Genetics Lab at Baylor College of Medicine before joining Vela Diagnostics
          • J. Russ Carmical, PhD
            Sequencing Director/Director of Operations, Alkek Center for Metagenomics and Micobiome Research (CMMR) at Baylor College of Medicine and Director of Operation of Diversigen
            Biography
              Russ is the Sequencing Director for the Alkek Center for Metagenomics and Microbiome Research (CMMR)at Baylor College of Medicine and Director of Operation for Diversigen, where he applies laboratory automation to metagenomic and microbiome sample processing for next generation DNA sequencing. The laboratory is CLIA/CAP accredited and offers regulated services to both academic and commercial collaborators. He is also one of the founding member of the International Metagenomics and Microbiome Standards Alliance (IMMSA) which was formed for the mutual benefit of the entire microbiome and metagenomics community and will focus specifically on coordinating cross-cutting efforts that address microbiome and metagenomic measurement challenges.
            • Scott Jackson, PhD
              Group Leader - Complex Microbial Systems, NIST
              Biography
                Undergraduate: Chemistry at University of South Carolina 1991-1996 Gradate: Univ. of Maryland and Johns Hopkins Univ - Biochemistry and Molecular Genetics 1996-2003 2003-2014 - Food and Drug Administration (FDA) Center for Food Safety. Principal Investigator. Developed Molecular Genetic Tools for the Identification of Foodborne Pathogens 2014-Present: NIST Group Leader - Complex Microbial Systems Group. Oversee new program focusing on Microbial Metrology. Co-founder of the International Metagenomics and Microbiome Standards Alliance (IMMSA)
              • Andreas Jeromin, PhD
                Chief Medical Officer (consulting), Quanterix Corp
                Biography
                  Andreas Jeromin, PhD, has more than 25 years of experience in CNS clinical diagnostics and companion diagnostics and co-authors more than 150 publications. He is the founder of Atlantic Biomarkers, Inc., and currently the consulting Chief Medical Officer to Quanterix Corp and member of several biomarker/CNS disorder consortia and working groups.
                • Roger Klein MD, JD, FCAP
                  Principal at Roger D. Klein, MD JD Consulting, Cleveland Clinic, Chair, Professional Relations Committee, Association for Molecular Pathology (AMP); Medical Director, Molecular Oncology
                  Biography
                    Roger D. Klein, M.D., J.D., serves as Medical Director of Molecular Oncologyo at Bloodcenter Of Wisconsin, Inc. Dr. Klein lead the development of BloodCenter of Wisconsin's Diagnostic Laboratories' newest initiative, which will focus on DNA- and RNA-based testing for evaluation of cancer patients.Dr. Klein is a national leader in the advancement of policies related to the implementation of genetic and genomic testing. Specifically, as relates to this webinar, he has been actively engaged in CPT coding, coverage and reimbursement issues with the College of American Pathologists, the Association for Molecular Pathology, and the American Medical Association Molecular Pathology CPT Advisory Group, and governmental panels such as the Medicare Evidence Development and Coverage Advisory Committee. He has played a leading role in the creation and maintenance of the Molecular Pathology section in the CPT Manual.
                  • Jason Kralj, PhD
                    Leader of the Metagenomic Pathogen Detection program, National Institute of Standards and Technology
                    Biography
                      Dr. Jason Kralj has worked at NIST since 2006, and is a member of the Complex Microbial Systems Group led by Scott Jackson. Currently, he is developing a pathogen DNA reference material to address some of the analytical challenges facing next generation sequencing-based metagenomics
                    • Ahmed Mahmoud, PhD
                      Director of Scientific Support for Vela Diagnostics, Bioinformatics Applications scientist
                      Biography
                        Ahmed Mahmoud is an experienced scientist with both hands-on lab and bioinformatics experience with degrees in both molecular biology and bioinformatics. Ahmed is currently the Director of Scientific Support for Vela Diagnostics as well as a Bioinformatics Applications scientist. Ahmed's team handles all technical wet lab and informatics support for Vela Diagnostic's qPCR and NGS workflows, assisting with pipeline creation for various NGS workflows and robotic application writing for automated systems. He has experience developing qPCR and Automated NGS workflows as well as extensive experience in NGS data analysis using multiple sequencing platforms. He has held positions in various areas of the biotech industry with institutions such as GeneDX, Pfizer and Columbia University Medical Center. Ahmed is also an avid iOS developer, creating computer apps geared towards the science sector.
                      • John Martignetti, MD, PhD
                        Icahn School of Medicine at Mount Sinai Departments of Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences
                        Biography
                          John A. Martignetti, MD, PhD, an expert in human genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, as the Network Director of the Laboratory for Translational Research at the WCHN Biomedical Research Institute. Under this collaboration, Dr. Martignetti's well-established bedside to bench cancer research methodology will be extended to patients at Danbury, Norwalk and New Milford hospitals leading to more personalized and successful therapeutic strategies. He will work closely with the oncology physicians and research scientists across WCHN to build on their nationally recognized efforts.
                        • Joel Parker, PhD
                          Director, Bioinfomatics, Associate Professor, University of North Carolina, Chapel Hill
                          Biography
                            Dr. Parker's research is focused in the methodological development and integrated analysis of high throughput genetic and genomic studies. He previously lead the development of algorithms and content resulting in ProsignaTM, the only CE marked and FDA 510(k) cleared breast cancer diagnostic assay for FFPE tissue. He is currently involved in similar diagnostic development in kidney and bladder cancer, and recently presented a novel predictive biomarker for enzalutamide in triple negative breast cancer which is being used as entry criteria for a phase III trial. Dr. Parker currently directs the sequencing, microarray, and other genomics analysis in the Bioinformatics Shared Resource at the Lineberger Comprehensive Cancer Center. The impact of his collaborative efforts are demonstrated in publications, which presently constitute >150 peer review publications.
                          • Bobbi Pritt, MD
                            Pathologist, Laboratory Medicine and Pathology, Mayo Clinic
                            Biography
                              Dr. Bobbi Pritt is a pathologist in Rochester, Minnesota and is affiliated with Mayo Clinic. She received her medical degree from The Robert Larner, M.D. College of Medicine at The University of Vermont and has been in practice between 11-20 years. She is one of 175 doctors at Mayo Clinic who specialize in Pathology.
                            • Randall Wolcott, MD
                              Medical Director, Southwest Regional Wound Care Center
                              Biography
                                Dr. Randall Wolcott is the founder of the Southwest Regional Wound Care Center in Lubbock, TX. The Wound Care Center specializes in biofilm-based wound care. The Wound Care Center offers state of the art technology with molecular diagnostics and state of the art alternative medicine including customized topical wound gels. He is passionate about healing wounds.
                              APR 12 - 13 2017
                              Molecular Diagnostics 2017
                              27 56 12320

                              The 2nd Annual Molecular Diagnostics Virtual Conference is now available On-Demand!   This conference is a premiere venue for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing. Attend this online event ondemand at no charge.

                              Join LabRoots in bringing together the Molecular Diagnostics community. Attend webcasts with top experts and interact with speakers during the live Q&A sessions. Earn continuing education credits and network with peers. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.
                               
                              Topics discussed at this years event included:

                              • Pursue Microbiome Testing as a Companion Diagnostic
                              • Diseases and Disorders
                              • Immunotherapy
                              • Regulatory Landscape
                              • Microbiome Standards related to Diagnostics
                              • Liquid Biopsies


                              Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global diagnostics community with a high degree of interaction through live-streaming video and chat sessions.

                              Continuing Education
                              By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

                              Use #LRmoldx to follow the conversation
                               


                              Speakers:
                              • Chief Medical Officer, Invitae
                              • Associate Professor Weill Cornell Medicine WorldQuant (WQ) Scholar & Director, WQ Initiative for Quantitative Prediction
                              • Consultant Senior Director, Clinical Research
                              • Vice President of Precision Oncology, Vela Dx
                              • Sequencing Director/Director of Operations, Alkek Center for Metagenomics and Micobiome Research (CMMR) at Baylor College of Medicine and Director of Operation of Diversigen
                              • Group Leader - Complex Microbial Systems, NIST
                              • Chief Medical Officer (consulting), Quanterix Corp
                              • Principal at Roger D. Klein, MD JD Consulting, Cleveland Clinic, Chair, Professional Relations Committee, Association for Molecular Pathology (AMP); Medical Director, Molecular Oncology
                              • Leader of the Metagenomic Pathogen Detection program, National Institute of Standards and Technology
                              • Director of Scientific Support for Vela Diagnostics, Bioinformatics Applications scientist
                              • Icahn School of Medicine at Mount Sinai Departments of Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences
                              • Director, Bioinfomatics, Associate Professor, University of North Carolina, Chapel Hill
                              • Pathologist, Laboratory Medicine and Pathology, Mayo Clinic
                              • Medical Director, Southwest Regional Wound Care Center

                              Show Resources
                              Agenda
                              All times are Pacific Time
                              • APR 12, 2017 06:00 AM PDT
                                Speaker: Jason Kralj, PhD
                              • APR 12, 2017 07:30 AM PDT
                                Speaker: Robert Nussbaum MD, FACP, FACMG
                              • APR 12, 2017 09:00 AM PDT
                                Speaker: Catherine Behrens, MD, PhD, FACOG
                                Sponsored By: Roche Diagnostics
                              • APR 12, 2017 10:30 AM PDT
                                Speaker: Joel Parker, PhD
                                Sponsored By: Nanostring Technologies
                              • APR 12, 2017 12:00 PM PDT
                                Speaker: Roger Klein MD, JD, FCAP
                              • APR 12, 2017 01:30 PM PDT
                                Speaker: J. Russ Carmical, PhD
                              • APR 13, 2017 06:00 AM PDT
                                Speaker: John Martignetti, MD, PhD
                              • APR 13, 2017 07:30 AM PDT
                                Speaker: Randall Wolcott, MD
                              • APR 13, 2017 09:00 AM PDT
                                Speaker: Christopher Mason, PhD
                              • APR 13, 2017 10:30 AM PDT
                                Sponsored By: Vela Diagnostics
                                Condie Carmack, PhD
                                Vice President of Precision Oncology, Vela Dx
                                Ahmed Mahmoud, PhD
                                Director of Scientific Support for Vela Diagnostics, Bi...
                              • APR 13, 2017 12:00 PM PDT
                                Speaker: Bobbi Pritt, MD
                              • APR 13, 2017 01:30 PM PDT
                                Speaker: Andreas Jeromin, PhD
                              • Microbiome Standards related to Diagnostics
                              • APR 12, 2017 06:00 AM PDT
                                Speaker: Jason Kralj, PhD
                              • APR 12, 2017 01:30 PM PDT
                                Speaker: J. Russ Carmical, PhD
                              • APR 13, 2017 09:00 AM PDT
                                Speaker: Christopher Mason, PhD
                              • Diseases and Disorders
                              • APR 12, 2017 07:30 AM PDT
                                Speaker: Robert Nussbaum MD, FACP, FACMG
                              • APR 13, 2017 12:00 PM PDT
                                Speaker: Bobbi Pritt, MD
                              • APR 13, 2017 01:30 PM PDT
                                Speaker: Andreas Jeromin, PhD
                              • Oncology
                              • APR 12, 2017 09:00 AM PDT
                                Speaker: Catherine Behrens, MD, PhD, FACOG
                                Sponsored By: Roche Diagnostics
                              • APR 12, 2017 10:30 AM PDT
                                Speaker: Joel Parker, PhD
                                Sponsored By: Nanostring Technologies
                              • APR 13, 2017 06:00 AM PDT
                                Speaker: John Martignetti, MD, PhD
                              • APR 13, 2017 10:30 AM PDT
                                Sponsored By: Vela Diagnostics
                                Condie Carmack, PhD
                                Vice President of Precision Oncology, Vela Dx
                                Ahmed Mahmoud, PhD
                                Director of Scientific Support for Vela Diagnostics, Bi...
                              • Regulatory Landscape
                              • APR 12, 2017 12:00 PM PDT
                                Speaker: Roger Klein MD, JD, FCAP
                              • Pursue Microbiome Testing as a Companion Diagnostic
                              • APR 13, 2017 07:30 AM PDT
                                Speaker: Randall Wolcott, MD
                              Posters

                              POSTER SUBMISSION GUIDELINES

                              Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

                               

                              SUBMIT YOUR ABSTRACT

                              Enter the following information to this Submission Form:

                              • Poster Title
                              • Your Name
                              • Your Institution
                              • Your Email
                              • Abstract describing the poster

                               

                              All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                               

                              If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster.  LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                               

                              Questions? Email Posters@LabRoots.com

                              LabRoots Policy

                              Sponsored By

                              For information on becoming a sponsor or exhibitor, please click here.


                              Continuing Education (CME/CE/CEU) Credits

                              The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                              Committee

                              To download the Program Committee brochure here.


                              • Bryan Cobb, PhD, FACMG

                                Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

                                See more See less
                              • Shawn Baker, PhD

                                Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                See more See less
                              • Judd Moul, MD, FACS

                                Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                See more See less
                              • Emily Hollister, PhD

                                Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                                See more See less
                              Help

                              General LabRoots Questions

                              For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                              Contact us

                              Virtual Events and Webinars

                              Supported Configurations

                              • Operating System Internet Explorer Firefox Chrome Safari
                                Vista IE8+ FF10+ Chrome15+
                                Windows 7 IE8+ FF10+ Chrome15+
                                Windows 8 IE10 FF10+ Chrome15+
                                Mac OS X   FF10+ Chrome15+ Safari5.1+
                              • Cookie settings: session cookies enabled
                              • Browser configuration must have JavaScript enabled
                              • Adobe Flash player 10.2 or later

                              To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                              Internet Connection

                              • A minimum of 100Kbps is recommended for audio-only events
                              • A minimum of 300Kbps is recommended for speaker on-video events

                              Computer Equipment

                              • Screen Resolution: Minimum 1024x768
                              • Video Card: 65,000 colors minimum
                              • Sound card and speakers (or headphones) for hearing webcast in full format
                              • Audio Card: 16-bit minimum
                              • RAM: 512MB of free RAM

                              Firewall Protocol

                              • HTTP on port 80 or HTTPS on port 443
                              • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                              • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                              Work-At-Home Attendees

                              • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                              For A Seamless Experience

                              When using a mobile device, FREE Mobile Apps are available:

                              - For viewing Webinars:

                              - For viewing Virtual Events

                              Attendee Guide

                              • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                              Virtual Event and Webinar Support:

                              Continuing Education (CME/CE) Support

                              Loading Comments...
                              Show Resources